ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Aug 27, 2014
Insider Transaction Report
Form 4
Rummelt Andreas
Director
Transactions
- Sale
Common Stock, par value $.0001 per share
2014-08-25$170.53/sh−5,052$861,518→ 12,786 total - Exercise/Conversion
Option to Purchase Common Stock
2014-08-25$49.43/sh−1,393$68,856→ 0 totalExercise: $49.43From: 2011-08-11Exp: 2021-05-11→ Common Stock, par value $.0001 per share (1,393 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2014-08-25$49.43/sh+1,393$68,856→ 17,838 total - Exercise/Conversion
Option to Purchase Common Stock
2014-08-25$24.36/sh−3,659$89,133→ 0 totalExercise: $24.36From: 2011-02-23Exp: 2020-02-23→ Common Stock, par value $.0001 per share (3,659 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2014-08-25$24.36/sh+3,659$89,133→ 16,445 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $170.46 - $170.62. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.